https://orcid.org/0000-0002-0565-5757
References
- Verhagen EA, ter Horst HJ, Keating P, et al. Cerebral oxygenation in preterm infants with germinal matrix-intraventricular hemorrhages. Stroke. 2010;41(12):2901–2907.
- Meek JH, Tyszczuk L, Elwell CE, et al. Low cerebral blood flow is a risk factor for severe intraventricular haemorrhage. Arch Dis Child Fetal Neonatal Ed. 1999;81(1):F15–F18.
- Noori S. Patent ductus arteriosus in the preterm infant: to treat or not to treat? J Perinatol. 2010;30(S1):S31–S37.
- Wolfberg AJ, du Plessis AJ. Near-infrared spectroscopy in the fetus and neonate. Clin Perinatol. 2006;33(3):707–28.
- Korček P, Straňák Z, Širc J, et al. The role of near-infrared spectroscopy monitoring in preterm infants. J Perinatol. 2017;37(10):1070–1077.
- Lemmers PM, Molenschot MC, Evens J, et al. Is cerebral oxygen supply compromised in preterm infants undergoing surgical closure for patent ductus arteriosus? Arch Dis Child Fetal Neonatal Ed. 2010;95(6):F429–F434.
- Heuchan AM, Clyman RI. Managing the patent ductus arteriosus: current treatment options. Arch Dis Child Fetal Neonatal Ed. 2014;99(5):F431–F436.
- Thébaud B, Lacaze-Mazmonteil T. Patent ductus arteriosus in premature infants: a never-closing act. Paediatr Child Health. 2010;15(5):267–270.
- Lemmers PMA, Toet MC, van Bel F. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants. Pediatrics. 2008;121(1):142–147.
- Dullenkopf A, Frey B, Baenziger O, et al. Measurement of cerebral oxygenation state in anaesthetized children using the INVOS 5100 cerebral oximeter. Pediatr Anesth. 2003;13(5):384–391.
- Sorenson LC, Greisen G. Precision of measurement of cerebral tissue oxygenation index using near-infrared spectroscopy in preterm neonates. J Biomed Opt. 2006;11:054005.
- Menke J, Voss U, Möller G, et al. Reproducibility of cerebral near infrared spectroscopy in neonates. Biol Neonate. 2003;83(1):6–11.
- Dix LML, Van Bel F, Lemmers PM. Monitoring cerebral oxygenation in neonates: an update. Front Pediatr. 2017;5:46.
- Plomgaard AM, van Oeveren W, Petersen TH, et al. The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury. Pediatr Res. 2016;79(4):528–535.
- Clyman RI, Couto J, Murphy GM. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol. 2012; 36(2):123–129.
- El-Khuffash A, Weisz DE, McNamara PJ. Reflections of the changes in patent ductus arteriosus management during the last 10 years. Arch Dis Child Fetal Neonatal Ed. 2016;101(5):F474–F478.
- El-Khuffash A, James AT, Corcoran JD, et al. A patent ductus arteriosus severity score predicts chronic lung disease or death before discharge. J Pediatr. 2015;167(6):1354–1361.e2.
- Hyttel-Sorensen S, Pellicer A, Alderliesten T, et al. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial. BMJ. 2015;350:g7635.
- Lemmers PM, Benders MJ, D’Ascenzo R, et al. Patent ductus arteriosus and brain volume. Pediatrics. 2016;137(4):pii:e20153090.
- Chock VY, Rose LA, Mante JV, et al. Near-infrared spectroscopy for detection of a significant patent ductus arteriosus. Pediatr Res. 2016;80(5):675–680.
- Benitz WE, Committee on fetus and newborn, American academy of pediatrics. Patent ductus arteriosus in preterm infants. Pediatrics. 2016;137(1):e20153730.
- Reese J, Laughon MM. The patent ductus arteriosus Problem: infants who still need treatment. J Pediatr. 2015;167(5):954–956.
- Weisz DE, Mirea L, Rosenberg E, et al. Association of patent ductus arteriosus ligation with death or neurodevelopmental impairment among extremely preterm infants. JAMA Pediatr. 2017;171(5):443–449.